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Background: Canine intervertebral disc disease (IVDD) represents a significant clinical
problem in veterinary medicine, with similarities to the human pathology. Host-derived
damage-associated molecular patterns like fibronectin fragments (FnF) that develop
during tissue dysfunction may be of specific relevance to IVD pathologies by inducing
an inflammatory response in resident cells.
Aim: This project aimed to determine the presence and pathobiological role of FnF during
IVD herniation in dogs, with a focus on inflammation.
Methods: Herniated nucleus pulposus (NP) material from five dogs as well as
non-herniated adjacent NP material from three dogs was collected during spinal surgery
required due to acute IVD herniation. The presence of different types of FnF were
determined by Western blot analysis. NP cells isolated from six herniated canine IVDs
were then exposed to 30 kDa FnF. NP cell inflammation and catabolism was examined
by investigating the expression of IL-1β, IL-6, IL-8, and COX-2, as well as MMP-1 and
MMP-3 by qPCR (all targets) and ELISA (IL-6, PGE2).
Results: Amongst multiple sized FnF (30, 35, 45, and >170kDa), N-terminal
fragments at a size of ∼30 kDa were most consistently expressed in all five herniated
IVDs. Importantly, these fragments were exclusively present in herniated, but not in
non-herniated IVDs. Exposure of canine NP cells to 500 nM 30 kDa FnF caused a
significant upregulation of IL-6 (62.5± 79.9, p= 0.032) and IL-8 (53.0± 75.7, p= 0.031)
on the gene level, whereas IL-6 protein analysis was inconclusive. Donor-donor variation
was observed in response to FnF treatment, whereby this phenomenonwasmost evident
for COX-2, with three donors demonstrating a significant downregulation (0.67 ± 0.03,
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p = 0.003) and three donors showing upregulation (6.9 ± 5.5, p = 0.21). Co-treatment
with Sparstolonin B, a TRL-2/TRL-4 antagonist, showed no statistical difference to FnF
treatment alone in all tested target genes.
Conclusion: Given the presence of the 30 kDa FnF in canine herniated IVDs and the
proinflammatory effect of 30 kDa FnF on NP cells, we concluded that the accumulation
of FnF may be involved in the pathogenesis of canine IVDD. These results correspond to
the findings in humans with IVDD.
Keywords: IVDD, neuroinflammation, intervertebral disc, DAMPs, NP cells, fibronectin fragments
INTRODUCTION
Intervertebral disc (IVD) disease (IVDD), including painful
degeneration and herniation, is considered a major cause of
acute and chronic low back pain not only in humans but
also in dogs (1, 2). Lower back pain is the main cause of
disability in humans and therefore has a tremendous socio-
economic impact. Similarly, in dogs, IVDD is a prevalent
disorder and shares many similarities in the clinical presentation,
but also potentially in its aetiopathogenesis (3, 4). While
the molecular disease mechanisms in humans, specifically the
mechanisms of inflammation during disc aging and degeneration
(= inflammaging) are well-investigated (5–8), considerably less
is known about the pathobiology of canine IVDD. Nevertheless,
similar to the situation found with humans, we and others could
demonstrate enhanced expression of proinflammatory cytokines
in herniated canine IVDs compared to non-herniated IVD
(9–11). The production and release of proinflammatory factors
can be mediated through numerous stimuli, including pathogen
recognition receptors such as toll-like receptors (TLRs), which
are expressed on the surface of IVD cells (12). TLRs can be
activated by pathogen-associated molecular patterns (PAMPs),
such as lipopolysaccharide (LPS) and also by specific damage-
associated molecular patterns (DAMPs) (13, 14). DAMPs are
host-specific, cell- or tissue-derived biomolecules that are
produced due to trauma, ischemia, and tissue damage. Unlike
PAMPs, DAMPs do not require the presence of pathogens. The
best known DAMP molecules include High-Mobility-Group-
Protein B1 (HMGB1), heat shock proteins (HSPs), S100 and
histones, but also certain matrix fragmentation products such
as hyaluronic acid fragments or fibronectin fragments (15, 16).
Fibronectin is a glycoprotein consisting of two subunits of
Abbreviations: BLAST, basic local alignment search tool; BSA, bovine serum
albumin; COX, cyclooxygenase; DAMPS, damage-associated molecular patterns;
DMEM, dulbecco’s modified eagle’s medium; ECM, extracellular matrix; EDTA,
ethylenediaminetetraacetic; ELISA, enzyme-linked immunosorbent assay; Fn,
fibronectin; FnF, fibronectin fragments; HSPs, heat shock proteins; IL, interleukin;
INF, interferon; IVD, intervertebral disc; IVDD, intervertebral disc disease; kDa,
kilodalton; LPS, lipopolysaccharide; MAPK, mitogen-activated protein kinase;
MMP, matrix metalloproteinases; MRI, magnetic resonance imaging; mRNA,
messenger ribonucleic acid; NF-kβ, nuclear factor kappa-light-chain-enhancer of
activated B cells; NP, nucleus pulposus; PAMPS, pathogen-associated molecular
patterns; PBS, phosphate buffered saline; PGE2, prostagalandine E2; PVDF,
polyvinylidenfluorid; RNA, ribonucleic acid; RT-qPCR, quantitative real-time
reverse transcriptase polymerase chain reaction; TBS-T, tris-buffered saline-tween;
TLR, toll-like-receptor; TNF, tumor necrosis factor.
∼220–250 kDa each, with high relevance in cell-to-cell and
cell-to-matrix adhesion (17). Fibronectin undergoes proteolytic
fragmentation upon exposure to numerous enzymes, resulting in
different sized fragments with different biological functionality:
N-terminal FnF (30 kDa, 70 kDa), Gelatin-binding 45 kDa FnF,
Cell-binding 120 kDa FnF, C-terminal FnF (40 kDa) (18).
We and others have previously demonstrated that the
expression of FnF is increased during IVD degeneration
in humans (19, 20). Furthermore, FnF appear to induce
degenerative and inflammatory processes characterized by an
increased expression of proinflammatory molecules such as
interleukin (IL)-6, IL-1β and increased activity of extracellular
matrix degrading enzymes (21–23). These processes are likely
mediated via TLRs, specifically TLR-2 and/or TLR-4, with
downstream activation of nuclear factor kappa-light-chain-
enhancer of activated B-cells (NF-κB) and mitogen-activated
protein (MAPK). Therefore, FnF may be important modulators
of degeneration and inflammaging (via disc cell inflammation)
during canine disc disease.
The aim of this project was to identify the presence of FnF
in IVD material from dogs suffering from IVD herniation.
Furthermore, we aimed to determine the inflammatory
and catabolic response of canine IVD cells upon exposure
to 30 kDa FnF, with and without inhibition of TLR-
2/TLR-4, to gain mechanistic insights in the pathobiology
of IVDD.
MATERIALS AND METHODS
Expression of FnF in Herniated and
Non-herniated Intervertebral Discs
Sample Collection
NP material was collected from client-owned dogs undergoing
routine spinal surgery at the Small Animal Clinic of the Vetsuisse
Faculty of the University of Bern, Switzerland due to acute onset
of an intervertebral disc herniation (Table 1). A board-certified
neurologist examined all dogs. After the lesion was localized,
patients were stabilized with individual pain management
therapy and further diagnostic workup was conducted. The
patients were included in the study if the diagnosis of an acute
IVD herniation was confirmed by an MRI. Patients presenting
any signs of an illness other than IVDD were excluded from
the study. Anesthesia was performed following a standard
protocol, including intramuscular sedation with methadone
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TABLE 1 | Signalement and clinical presentation of the dogs included into the study.
Nb Breed Gender Onset (days) Clinical presentation Age at surgery/blood donation
Candidates for western blot
Affected
1 French bulldog Female
intact
1 Tetraplegia 6 years,8 months,5 days
2 Dachshund Male
intact
1 Non-ambulatory paraparesis 7 years,11 months,28 days
3 French bulldog Male
castrated
0.5 Non-ambulatory paraparesis 5 years,8 months,17 days
4 Toy poodle Male
castrated
3 Paraplegia without deep pain 11 years,5 months,0 days
5 French bulldog Male
intact
3 Ambulatory paraparesis 3 years,10 months,16 days
Controls
4 Toy poodle Male
castrated
3 Paraplegia without deep pain 11 years,5 months,0 days
6 Dachshund Female
spayed
6 Non-ambulatory paraparesis 6 years,8 months,2 days
7 American staffordshire terrier Male
castrated
3 Non-ambulatory paraparesis 7 years,10 months,14 days
Candidates for IVD cell cultures
8 French bulldog Male
intact
1 Ambulatory paraparesis 8 years, 2 days
9 French bulldog Male
castrated
1 Ambulatory paraparesis 6 years, 9 months, 29 days
10* French bulldog Male
intact
1 Pain 6 years, 4 days
11* French bulldog Male
intact
1 Pain 6 years, 4 days
12 Beagle Female
intact
1 Non-ambulatory tetraparesis 8 years, 8 months, 6 days
13 Maltese Female
spayed
1 Ambulatory paraparesis 3 years, 8 months, 27 days
Summary of the total study population. NP material collected from the spinal canal formed the diseased IVD group, NP collected from adjacent IVD served as healthy controls. *This
dog had two simultaneous herniations at two different sites.
(0.2 mg/kg) and acepromazine (0.03 mg/kg, Arovet AG, 8953
Dietikon, Switzerland), induction with intravenous propofol (2–8
mg/kg to effect, 16NC3652, Fresenius Kabi, 6370 Oberdorf,
Switzerland) and maintenance with isoflurane in an air-oxygen
combination, delivered with a rebreathing system (1.2–2% end-
tidal isoflurane concentration). Subsequent routine ventral slot
(cervical disc herniation) or hemilaminectomy (thoracolumbar
disc herniation) was performed and herniated NP material
retrieved from the spinal canal. Prophylactic fenestration (only
in the thoracolumbar spine, but not in the cervical spine) of
the adjacent IVD was performed as it might be prone to a
future herniation (24–26). While NP material collected from
the spinal canal formed the diseased IVD group, NP received
from adjacent IVD served as non-herniated controls. The non-
herniated control tissue was obtained from the same dogs that
underwent surgery for the herniated disc, but from an adjacent
disc via fenestration. The degree of IVD degeneration was
assessed by high-field MRI images using the Pfirrmann grading
system (27, 28). Collected herniated NP and non-herniated
(control) NP material was shock frozen in liquid nitrogen and
stored at−80◦C for analysis of fibronectin fragmentation. For
cell isolation, NP material was collected in DMEM/F12 (31,330-
038, Thermo Scientific,Waltham,MA, USA) with 3%Antibiotic-
Antimycotic (15,240,062, Gibco Life Technologies, Switzerland).
More details about the cell isolation are provided in section
Effects of Human 30 kDa FnF on Canine IVD Cells in vitro
below). Informed written owner consent was obtained for each
dog. Every procedure performed for this study was approved by
the commission of animal experimentation of the canton of Bern,
Switzerland (31496).
Protein Extraction
For protein isolation, frozen NP specimens were pulverized
using a custom-made cryo-pulverizer (mortar and pestle), then
placed into RIPA buffer (89,900, Thermo Scientific), 0.5M EDTA
Solution 10 × (1,860,851, Thermo Scientific) and Halt Protease
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Inhibitor Single-Use Cocktail (78,430, Thermo Scientific) and
incubated on ice for 30min on an orbital shaker. Samples then
were further ground using a Polytron PT 2500E (Kinematica
AG, 6014 Lucerne, Switzerland) before final centrifugation at
12,000 × g for 20min at 4◦C. The supernatant of the samples
was transferred to a new tube, and the total protein content was
quantified by standard Bradford’s Protein Assay (5,000,006, BIO-
RAD Laboratories Inc., California 94547, USA) according to the
manufacturer’s recommendations. Total protein concentrations
of the samples were calculated using the values from the
standards as references.
Western Blotting
Twenty micrograms of each protein sample was boiled in
4 × Laemmli Sample Buffer (1,610,747, BIO-RAD) without
β-mercaptoethanol at 95◦C for 2min on an orbital shaker
at 300 rpm. As a positive control, the 30 kDa proteolytic
fragments from human plasma fibronectin (F9911, Sigma-
Aldrich Chemie GmbH, 9471 Buchs SG, Switzerland) were used
in a concentration of 1 × 10−4 µg and treated equally. 4–
15%Mini-PROTEAN R© TGX Stain-FreeTM Protein Gels, ten well,
30 µL (4,568,083, BIO-RAD) were loaded with 1.5 µl page
rulerTM Pre-stained protein ladder (26,616, Thermo Scientific),
1 × 10−4 µg of the positive control and 20 µg of each sample.
Proteins were separated by electrophoresis at 130V for 80min
and then electroblotted onto Trans-Blot R© TurboTM Mini PVDF
transfer packs (1,704,156, BIO-RAD) using the Trans-Blot R©
TurboTM Transfer-System (BIO-RAD). Appropriate loading was
verified by imaging the membranes with the ChemidocTM
Touch Imaging System (BIO-RAD) prior to blocking with
3% bovine serum albumin (BSA, A7906, Sigma-Aldrich)
in tris-buffered saline-tween (TBS-T) at room temperature
for 1 h. Before incubation with the primary antibody, the
membranes were washed three times with TBS-T for 10min. The
primary monoclonal mouse anti-fibronectin antibody-specific
to the N-terminus of fibronectin (7D5, provided by Prof.
Deane Mosher, University of Wisconsin), was applied in a
concentration of 1:1,000 in 3% BSA, in TBS-T at 4◦C, overnight.
Before incubation with the secondary anti-mouse horseradish
peroxidase linked antibody (7076, Cell Signaling Technology R©,
2,316 WZ Leiden, Netherlands) in a concentration of 1: 10,000
in 3% BSA/TBS-T at room temperature for 1 h, the membranes
were washed three times with TBS-T. After three final 10min
washing steps in TBS-T, chemiluminescence was detected using
SuperSignalTM West Pico PLUS Chemiluminescent Substrate
(34,577, Thermo Scientific). Images were processed and analyzed
using ChemidocTM Touch Imaging System (BIO-RAD).
Effects of Human 30 kDa FnF on Canine
IVD Cells in vitro
Isolation of IVD Cells
Canine IVD cells were isolated from six patients (Table 1)
undergoing spinal surgery (hemilaminectomy) due to an acute
thoracolumbar IVD herniation as described above. Harvested
IVD tissue was immediately immersed in serum-free transport
medium (DMEM/F12), supplemented with 3% Antibiotic-
Antimycotic. The harvested IVD tissue was then enzymatically
digested using 0.2% collagenase NB4 (S1745401, Nordmark
Biochemicals, 25436 Uetersen, Germany) and 0.3% dispase
II (13437500, Sigma-Aldrich) dissolved in phosphate buffered
saline (PBS, 09-8912-100, Medicago AB, SE-755 98 Uppsala,
Sweden) for 6 h at 37◦C. After the enzymatic isolation, the cells
were expanded in growth medium consisting of DMEM/F12,
supplemented with 10% fetal calf serum (FCS, F7524, Sigma-
Aldrich) and 1% Antibiotic-Antimycotic at 37◦C with 5% CO2
up to the fourth passage.
Exposure of Canine IVD Cells to 30 kDa Fibronectin
Fragments
For the stimulation experiments, IVD cells were cultured for 24 h
in a 6-well plate at a density of 2 × 105 cells/well in DMEM/F12
supplemented with 1%Antibiotic-Antimycotic and 10% FCS. On
the next day, cells were serum starved in media supplemented
with Polymyxin B (100 units/mL, 81271, Sigma-Aldrich) with or
without Sparstolonin B (SsnB, 25µM, TRL-2/TRL-4 inhibitor,
SML1767, Sigma-Aldrich) for 2 h prior to stimulation with FnF.
Afterwards, cells were treated with 30 kDa proteolytic fragments
from human plasma fibronectin (FnF, 500 nmol/L, F9911, Sigma-
Aldrich) or recombinant canine IL-1β, which was used as positive
inflammation control (10 ng/ml, 3747-CL-025, R&D Systems,
Inc., Minneapolis, MN 55413, USA) for 18h. Untreated NP
cells served as a negative control group, NP cells treated with
Sparstolonin B alone were used as a control to the combination
treatment of FnF, and Sparstolonin B. Used concentrations were
based on the range of FnF found in IVDs during degeneration
(19, 29). After the incubation time, media supernatants were
collected, and cells were lysed using RLT Lysis Buffer (79,216,
Qiagen, Hilden, Germany). Both cell lysates and supernatants
were stored at−80◦C until further analysis.
Reverse Transcription
Total RNA from IVD cell lysates was isolated and purified
using the RNeasy Mini Kit (74,104, Qiagen) according to
the manufacturer’s protocol without adjustments. Quantity and
quality of RNA were assessed using the NanoDropTM 1000
Spectrophotometer (Thermo Scientific). One µg total RNA was
reverse transcribed to cDNA using the reverse transcription
reagents from TaqMan R© (N808-0234, Applied Biosystems,
Foster City, CA, USA). Briefly, one sample consisted of 6.6
µL of 10× Taqman buffer (4,311,235, Applied Biosystems),
14.52 µL of 25mM MgCl2 (100,020,476, Applied Biosystems),
13.2 µL dNTP mix (45–100, Applied Biosystems), 3.3 µL of
Random hexamer (N8080127, Thermo Scientific), 1.32 µL of
RNase inhibitor (100,021,540, Applied Biosystems), 1.65 µL
of reverse transcriptase (4,311,235, Applied Biosystems) that
was added to 1 µg of total RNA. Finally, the volume was
adjusted to 60 µL with RNase free water (1018017, Qiagen)
and reverse-transcribed by the T100TM Thermal Cycler (BIO-
RAD) performing 10min cycle at 25 ◦C, followed by 120min
cycle at 37◦C. cDNA samples were then stored at −20◦C until
further analysis.
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TABLE 2 | Identification numbers of TaqMan primers (TaqMan® Gene Expression
Assays, Thermo Scientific) used in the present study.
Target gene Assay ID Correlation to inflammatory process
GAPDH Cf04419463_gH Reference gene
IL-1β Cf02671951_g1 Proinflammatory cytokine (5)
IL-6 Cf02624153_m1 Proinflammatory cytokine (5)
IL-8 Cf02624283_m1 Proinflammatory cytokine (5)
MMP1 Cf02651000_g1 Collagen (I, II, III) cleavage (57)
MMP3 Cf02625960_m1 Proteoglycan and collagen (II, III) cleavage
(57)
COX-2 Cf02680566_gH Mediator of pain (58)
GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; IL-1β, interleukin 1 beta; IL-6,
interleukin 6; IL-8, interleukin 8; MMP1, matrix metalloproteinase 1; MMP3, matrix
metalloproteinase 3; COX-2, cyclooxygenase-2.
Quantitative RT-PCR (qPCR)
For qPCR, each reaction mix consisted of cDNA (10 ng/well)
diluted with RNase free Water (1,018,017, Qiagen) to a total
volume of 4.5 µL, TaqMan R© Fast Universal PCR Master Mix
2× (5µL/well, 4367846, Applied Biosystems) and canine-specific
TaqMan primers (0.5 µL/well, Table 2). Real-time analysis of
mRNA expressionwas quantified using C1000TM Touch Thermal
Cycler, CFX96TM Real-Time System (BIO-RAD). Each reaction
was performed in duplicates in a Micro Amp R© Fast Optical
96-Well Reaction Plate 0.1mL (4,346,906, Applied Biosystems)
with the amplification condition set to one cycle at 95◦C for
20 s, followed by 44 cycles of 95◦C for one second and 60◦C for
20 s. Data processing of the obtained Cq-values was conducted
using the 2−11CT method and presented as the fold change
in gene expression normalized to the reference gene GAPDH
and relative to a control condition (30). Cultures treated with
fibronectin fragments were normalized to the untreated controls,
and samples treated with fibronectin fragments and Sparstolonin
B were normalized to samples with Sparstolonin B alone.
Enzyme-Linked Immunosorbent Assay (ELISA)
Secreted IL-6 and PGE2 were evaluated in the cell culture
supernatant by commercially available ELISA kits (CA6000,
R&D Systems, Minneapolis, MN. USA; KGE004B, R&D Systems)
following the manufacturer’s protocol. Samples were used
undiluted, and each sample was tested in duplicates. The
absorbance was measured (Tecan, Infinite M200 PRO) at
450 nm (with subtracted 540 nm absorbance). IL-6 and PGE2
concentrations were calculated based on the standard curve.
Results are presented as pg/mL.
Statistical Analysis
Data were checked for consistency and normality. Paired one and
two sample tests based on classical statistics (t-tests), bootstrap
methods (bootstrap t-tests) as well as non-parametric tests
(Wilcoxon signed-rank test) were used to analyse the data. A
significance level of 5% was taken to be statistically significant.
Whisker plots were used to illustrate the results. All statistical
analyses in this report were performed by the use of NCSS
(NCSS 10, NCSS, LLC. Kaysville, UT) and STATISTICA 13 (Hill,
T. & Lewicki, P. Statistics: Methods and Applications. StatSoft,
Tulsa, OK).
RESULTS
Study Population
A total number of 13 client-owned dogs were enrolled in the
present study (Table 1).
Seven dogs with an acute IVD herniation were investigated for
the presence of FnF. Five herniated IVDs served as the diseased
samples, and three non-herniated IVDs served as controls. The
study population consisted mainly of chondrodystrophic small
breed dogs, which are most often affected by IVDD. Due to the
small size of these canine patients, the surgically obtained sample
volumes were minimal. Therefore, sufficient material from both
the herniated (hemilaminectomy; diseased), but also a non-
herniated IVD (fenestration; control), could only be collected
from one of the seven dogs. In four dogs, the quantity of the
material collected from the herniated IVD, but not from the non-
herniated site, was sufficient for the experiments. In two dogs, it
was possible to obtain enoughmaterial from a non-herniated, but
not from the herniated IVD. The Pfirrmann grade of the IVDs
in the control group (non-herniated IVD material collected by
fenestration) was consistently lower (grade III) than the IVD in
the diseased group (grade V).
For the NP cell isolation and culture, herniated IVD material
from another 6 dogs was used and investigated for their
inflammatory response upon exposure to FnF.
Expression of Fibronectin Fragments in
Herniated Intervertebral Disc Material
Western blot analysis of herniated IVD material with the
mouse anti-fibronectin antibody specific to the N-terminus of
fibronectin (antibody 7D5, kindly provided by Prof. Deane
Mosher) revealed multiple sized FnF (Figure 1). All herniated
IVD specimens showed one band at a molecular weight at ∼30
kDa. Moreover, three herniated IVDs (patients 3, 4, and 5) also
displayed bands at a molecular weight of around 44 kDa, and one
herniated NP (patient 3) showed a band at a molecular weight
of ∼35 kDa. Additionally, 170 kDa fragments were infrequently
detected in herniated IVDs. Importantly, no FnF were detected
in the three non-herniated control IVD samples (Figure 1).
Effects of 30 kDa FnF Stimulation (Gene
Expression)
To study the effect of FnF on IVD inflammation, NP cells
were stimulated with 500 nM 30 kDa fragments of plasma
fibronectin (alone or in combination with the TRL-2/TRL-4
inhibitor Sparstolonin B) for 18 h. Gene expressions changes are
presented in Figure 2 (IL-1β, IL-6, IL-8), Figure 3 (COX-2), and
Figure 4 (MMP-1, MMP-3, positive control).
FnF treatment led to a statistically significant upregulation of
IL-6 (p = 0.032, Figure 2B) and IL-8 (p = 0.031, Figure 2C)
as compared to the untreated control. Donor-donor variation
was evident in response to FnF treatment and is indicated with
black and gray colors, with three donors showing a small to
moderate response (3.3 ± 0.1 for IL-6; 3.6 ± 1.8 for IL-8), and
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FIGURE 1 | Detection of fibronectin fragments in herniated and non-herniated canine nucleus pulposus material. FnF were detected using a mouse monoclonal
antibody specific for the N-terminal end of fibronectin. (A) Lane 1: 1 × 10−4 µg, 30 kDa proteolytic fragments from human plasma fibronectin (F9911, Sigma-Aldrich);
Lane 2: Patient 1; Lane 3: Patient 2; Lane 4: Patient 3; Lane 5: Patient 4; Lane 6, Patient 5; (B) Lane 1: 1 × 10−4 µg, 30 kDa proteolytic fragments from human
plasma fibronectin (F9911, Sigma-Aldrich); Lane 2: Patient 4; Lane 3: Patient 6; Lane 4: Patient 7; (for patient description see Table 1); (C) Density values of the
bands between 27 and 29.2 kDa of all donors. Black points represent the individual bands of the corresponding donors (A,B) and their respective signal intensity in
relation to the positive control group (Band 1: 30 kDa FnF). Data is presented as mean and 95% CI. *denotes statistically significant differences with p < 0.05.
FIGURE 2 | Gene expression of IL-1β (A), IL-6 (B), and IL-8 (C) after 18 h exposure to 30 kDa fibronectin fragments (500 nM) alone and in combination with the
TRL-2/TRL-4 inhibitor Sparstolonin B. Values were normalized to the reference gene (GAPDH) and are shown as fold change compared to untreated control (for
500 nM FnF) or Sparstolonin B alone (for 500 nm FnF + SsnB). *Denotes statistically significant differences with p < 0.05. Black symbols indicate high responders (n
= 3) and gray symbols indicate low responders (n = 3) (n = 6 total). Points demonstrate NP cells treated with 500 nM 30 kDa FnF. Triangles demonstrate NP cells
treated with a combination of FnF and Sparstolonin B.
three donors showing a moderate to strong response (121.7 ±
73.8 for IL-6; 102.3 ± 83.8 for IL-8, respectively). IL-1β mRNA
demonstrated negligible downregulation (p= 0.036, Figure 2A).
The responder phenomenon wasmost evident for COX-2mRNA
expression, where three out of six donors demonstrated a
statistically significant downregulation (0.67 ± 0.03, p = 0.003,
Figure 3B). In contrast, the other three donors showed a mild
trend toward an upregulation (not statistically significant, 6.9 ±
5.5, p= 0.21, Figure 3C). FnF treatment did however not result in
a significant change in MMP-1 (p = 0.29, Figure 4A) or MMP-3
(p= 0.21, Figure 4B) mRNA expression.
Co-treatment with Sparstolonin B (TRL-2/TRL-4 antagonist)
did not show any statistical difference compared to FnF treatment
alone in all tested gene targets (Figures 2–4).
When NP cells were stimulated with IL-1β as a
proinflammatory control, they exerted a strong and statistically
significant upregulation of all measured markers, as shown in
Figure 4C (IL-1β p = 0.026; IL-6 p = 0.011; IL-8 p = 0.0001;
MMP-1 p= 0.047; MMP-3 p= 0.003; COX-2 p= 0.022).
Effects of 30 kDa FnF Stimulation (Protein
Expression)
IL-6 release into the cell culture medium was detected
in the positive control (IL-1β treatment) in all donors
(Supplementary Figure 3A). However, it could only be detected
in two out of six donors in the 500 nM FnF group (2.19 and 2.76
pg/mL) and the 500 nM FnF group+ 25µM SSnB (5.84 and 14.8
pg/mL), as well as in one out of six donors in the 25µM SSnB
group (0.57 pg/mL).
Due to the limited range of the sensitivity (39.0–2,500 pg/mL)
of the PGE2 ELISA kit, the release of PGE2 (as a product of COX-
2) could not be detected in any of the tested samples except for the
positive control (IL-1β treatment, Supplementary Figure 3B).
DISCUSSION
It is well-established that canine IVD herniation is the result of a
course of complex biomechanical and biological interactions that
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FIGURE 3 | Gene expression of COX-2 after 18 h exposure to 30 kDa fibronectin fragments (500 nM) alone and in combination with the TRL-2/TRL-4 inhibitor
Sparstolonin B. All donors (A) and split according to low responders (B) and high responders (C). mRNA was quantified by real time RT-qPCR (RT-qPCR). Values of
COX-2 were normalized to the reference gene (GAPDH) and presented as the fold change compared to untreated control (FnF stimulation alone) or NP cells treated
with Sparstolonin B alone. *Denotes statistically significant differences with p < 0.05. Due to significant donor variation, low and high responders are displayed in a
separate graph (B,C). Points demonstrate NP cells treated with 500 nM 30 kDa FnF. Triangles demonstrate NP cells treated with a combination of FnF and
Sparstolonin B. The color black indicates high responders and the color gray indicates low responders. *Denotes statistically significant differences with p < 0.05 and
**p < 0.01.
resemble the human pathology (31–34). However, the current
understanding of the exact molecular patho-mechanisms of
IVD degeneration and herniation in dogs is still poor. To the
best of our knowledge, no study has thus far been conducted
on the role of DAMPs in canine IVDD. In human patients,
extracellular matrix (ECM) degradation through proteases
and inflammation, which can (amongst other mechanisms)
be induced by degeneration-associated DAMPs (12, 35, 36),
contribute to degenerative disc disease.
Amongst the various ECM fragments, FnF have attracted
much attention over the past decades as research in rodents
and humans has provided clear evidence for the presence of
FnF during IVD degeneration (22, 23, 37). Importantly, FnF
potentially contribute to the disease through induction of matrix
degradation and inflammation and suppression of proteoglycan
synthesis, specifically through the 30 kDa N-terminal FnF (22,
23, 37, 38). In the present study on canine IVDs, we were not
only able to demonstrate multiple sized FnF in herniated canine
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FIGURE 4 | Gene expression of MMP-1 (A) and MMP-3 (B) after 18 h exposure to 30 kDa fibronectin fragments (500nM) alone and in combination with the
TRL-2/TRL-4 inhibitor Sparstolonin B. Gene expression of IL-1β, IL-6, IL-8, COX-2, MMP-1, and MMP-3 after 8h exposure to canine IL-1β (C). mRNA was quantified
by real time RT-qPCR (RT-qPCR). Values of MMP-1 and MMP-3 were normalized to the reference gene (GAPDH) and presented as the fold change compared to
untreated control (FnF stimulation alone) or NP cells treated with Sparstolonin B alone (A,B). Values of IL-1β, IL-6, IL-8, MMP-1, MMP-3, and COX-2 were normalized
to the reference gene (GAPDH) and presented as the fold change compared between IL-1β treatment and untreated controls (C). *Denotes statistically significant
differences with p < 0.05. Points demonstrate NP-cells treated with 500nM 30kDa FnF. Triangles demonstrate NP cells treated with a combination of FnF and
Sparstolonin B. The color black indicates high responders and the color gray indicates low responders. *Denotes statistically significant differences with p < 0.05,
**p < 0.01 and ****p < 0.0001.
NP material, but also their potential proinflammatory activity
on a cellular level. Within the retrieved specimens of herniated
canine IVDs, FnF with a molecular weight of around 30 kDa
were most consistently present. Importantly, we could not detect
any FnF within NP material that was not herniated, as shown in
Figure 1. The observed molecular weight variance of the bands
around 30 kDa between samples and the positive control (30 kDa
proteolytic fragments from human plasma fibronectin) could
therefore be associated with donor dependent progressive protein
degradation or alternative splice variants during the degeneration
of the extracellular matrix of the IVD (39, 40). We also found
FnF with a molecular weight of ∼45 and 35 kDa in herniated
canine IVDs. Stanton et al. (41) showed that a 45 kDa collagen-
binding fragment of Fn can induce MMP-13 synthesis in porcine
chondrocytes and therefore demonstrates catabolic properties.
FnF of 35 kDa size have thus far not been specifically described
in the context of tissue dysfunction or degeneration but may
represent an intermediate fragmentation product, similar to the
larger fragments (>170 kDa) that were infrequently present.
The 30 kDa FnF, which was the most abundant size in the
current study, has previously been shown to have degradative and
inflammatory properties during human IVDD in vitro (20) and
during rabbit IVDD in vivo (37). To demonstrate not only the
presence but also the proinflammatory and degradative capacity
of 30 kDa FnF, IL-1β, IL-6, IL-8, and COX-2 as well as MMP-
1, MMP-3–cytokines and matrix degrading enzymes known to
promote matrix degradation and chemokine production during
IVDD–were measured in canine NP cells upon FnF treatment
(42). We are able to show that 30kDa FnF significantly increased
gene expression of IL-6, IL-8, and partially COX-2 compared to
control NP cells, whereas minor or non-significant changes were
observed for IL-1β, MMP-1 and MMP-3.
The induction of IL-6 and IL-8 in canine NP cells is similar
to previously described results in human IVD cells (21). The
involvement of IL-6 and IL-8 in the pathobiology of IVD
degeneration is well-established. One study in dogs showed an
upregulation in the gene expression of IL-8 and downregulation
in the gene expression of IL-6 during IVDD (11). Increased levels
of IL-6 and IL-8 in IVD in humans correlate with degeneration
and inflammation within the IVD (36, 43–46). Aside from
its catabolic effects on NP cells, IL-6 is also involved in the
development of pain during the course of IVDD (47). IL-8 is the
classical activator of neutrophils and has also been detected in
increased levels during IVDD in humans (45).
Interestingly, we observed that three donors demonstrated
a low to moderate response to 30 kDa FnF, whereas three
donors responded in a clear manner. The three donors with
the less pronounced response pattern were cryopreserved cells,
indicating that the process of cryopreservation may affect their
sensitivity to FnF. It is known; from work with germ cells that
cryopreservation can lead to genomic alterations or damage,
for example, deletions, base modifications or crosslinks on
the DNA, which, therefore, could explain an altered reaction
pattern between fresh and cryopreserved cells (48, 49). A study
evaluating the effect of cryopreservation on the viability of canine
and human NP cells did not show differences in proliferation
capacity, cell viability, and ability to produce extracellular matrix.
However, this study did not measure the potential of the NP cells
to react to proinflammatory stimuli (50).
COX-2 is a key enzyme in the regulation of PGE2 synthesis
and plays an important role in inflammation. It is induced in
many types of cells by the stimulation of inflammatory cytokines
such as IL-1β and tumor necrosis factor alpha (TNF-α) and
has been confirmed in IVD material from humans with lumbar
IVD herniation (51). In this study, COX-2 showed disparate
mRNA response patterns between fresh and frozen cells, with
FnF significantly inhibiting or tendentially inducing COX-2
expression, respectively.
As the effect of 30kDa FnF exposure on the gene expression
of canine NP cells was most promising for IL-6 and COX-
2, these markers were also tested on the protein level.
However, results were inconclusive due to detectability issues
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in untreated controls, and FnF stimulated cells. However,
exposure of NP cells to the positive control IL-1β led to a
marked increase in the production of both measured markers,
illustrating that the assays functioned appropriately. The use
of more sensitive tests or the analysis of protein levels at later
treatment time points might help to circumvent the observed
detection problems.
After the confirmation of the inflammatory potential of
30 kDa FnF, we aimed to identify the responsible underlying
molecular mechanism. The relevance of the TLR pathway
in IVD degeneration has been demonstrated in previous
investigations (52, 53). Although FnF have been described
as modulates of TLR-2 and TLR-4 in various cell types, for
example NP cells (35), articular chondrocytes (54), and mast
cells (55), we did not observe any reduction of FnF induced
inflammation with SSnB co-treatment. SSnB was shown to
selectively block TLR-2 and TLR-4 by inhibiting the early
intracellular steps in TLR-2 and TLR-4 signaling. It does not
block TLR-3 and TLR-9 (56). Interestingly, previous work
on human IVD disc inflammation with Cutibacterium acnes
reported involvement of TRL-2/TRL-4 in IVD inflammation,
but only in a subset of patients (57). Besides that, it
could be possible that the 30 kDa FnF, which is specific
for TRL-2/TRL-4 in humans (35), signals through other
receptors in dogs, such as the NOD2 (nucleotide-binding and
oligomerization domain) pathways, as shown in human articular
chondrocytes (58).
In this study, we compared herniated and non-herniated
NP tissue, with the non-herniated NP materials showing a
lower degeneration grade throughout. Ideally, the non-herniated
control IVD material would have consisted of healthy, non-
degenerated IVDs. In the clinical setting of client-owned dogs;
however, this is an unrealistic requirement as themajority of dogs
undergoing surgery for IVD herniation are chondrodystrophic
and therefore suffer from various stages of generalized IVDD. A
different study set-up using control dogs with healthy IVDwould
be necessary to investigate the situation in non-degenerated
IVD reliably. In a human study, significantly elevated levels
of fibronectin were present only in higher grades of IVD
degeneration (19). This is, therefore, in concordance with the
findings in our study, as FnF were detected only in the diseased,
herniated IVD but not in the non-herniated control IVD,
despite the presence of lower grade signs of degeneration in this
group. The herniation itself is a traumatic event, which often
involves disruption of local spinal blood vessels with subsequent
hemorrhage. Fibronectin is not only a protein abundantly present
in the ECM, but is also a blood component. Although gross
macroscopic evaluation did not show the presence of blood in the
collected tissue samples, we cannot exclude the presence of blood.
However, as FnF were also detected in human degenerated IVDs
(19) without herniation, i.e., in poorly vascularized structures
(59), we believe that the detected FnF originate from the
herniated IVD tissue.
It is important to note that we used commercially available
human 30 kDa FnF for the cell stimulation experiments.
Performing human and canine fibronectin amino acid alignment
of the Fn1 subunit of fibronectin with Basic Local Alignment
Search Tool (BLAST, https://blast.ncbi.nlm.nih.gov/Blast.cgi)
shows ∼70.6% identity. In contrast, if comparing only the
30 kDa N-terminal end of human and canine fibronectin, an
amino acid alignment of ∼99.55% was found. The suitability of
using human 30 kDa FnF to treat canine NP cells is evidenced
by the observed response patterns, specifically the significant
induction of IL-6 and IL-8. The concentration of FnF used in
our study was based on concentrations used in studies of human
IVDD (29). Ruel et al. (29) estimated the naturally occurring
concentrations of FnF in degenerated human IVDs at nanomolar
levels, by the signal intensity during western blot. Aside from NP
cells, invading macrophages during IVD herniation may also be
sensitive to FnF. Certain FnF can affect macrophage activation
and polarization (60) and compared to NP cells. Macrophages
are more potent immune modulators. Subjected to an adequate
stimulus, macrophages are known to be able to produce a variety
of proinflammatory cytokines, including TNFα, IL-1β, and IL-6.
They are thought to be the dominant regulator of the secretion
of MMP-1 and MMP-3 (61–64). Recently we could demonstrate
the occurrence of both M1 inflammatory macrophages and
M2 pro-healing macrophages in herniated IVDs, but not in
healthy control IVDs of dogs (unpublished data) (65). Therefore,
further work on the reaction of macrophages upon exposure to
FnF might provide valuable insights into the pathobiology of
canine IVDD.
CONCLUSION
In conclusion, we were able to demonstrate the presence of
FnF of various sizes in canine IVDs suffering from acute IVD
herniation, specifically those of∼30 kDa. Furthermore, exposure
of NP cells to 30 kDa FnF resulted in increased gene expression
of proinflammatory cytokines (IL-6 and IL-8). This finding
indicates that the accumulation of FnF in the canine IVD might
be involved in maintaining and promoting IVD degeneration
and inflammation. Future work must be implemented to
assess the impact of FnF accumulation in the pathobiology of
IVDD. Furthermore, the involvement of immune cells, especially
macrophages, in FnF induced inflammation, should be included
in future studies.
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